Eating Disorders - Protecting your oral health

Eating Disorders & GLP-1 RAs

Glucagon-like peptide-1receptor agonists (GLP-1 RAs), such as semaglutide (Ozempic), are medications originally developed to treat type 2 diabetes.

NEDC Credentialing Consultation Report 2020

After over six months of consultation with the eating disorders community and wider health sector, NEDC has published a consultation report which outlines our findings.

NSW Health Mental Health for Emergency Departments – A reference guide

Assessment & treatment of children and adolescents with eating disorders in Queensland

The aim of this guideline is to assist staff within Queensland Health Child and Youth Mental Health Services (CYMHS), Departments of Emergency Medicine, inpatient mental health units and paediatric medical wards when assessing a child or adolescent with a possible eating disorder, and deciding the most appropriate placement, treatment and care for the child or adolescent where admission to hospital is required.